Question 1

What specific types of cancer are being treated in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients clinical trial (NCT01363232). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of BKM120 and MEK162 work?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients clinical trial (NCT01363232). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients clinical trial (NCT01363232). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients clinical trial (NCT01363232). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients clinical trial (NCT01363232). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients clinical trial (NCT01363232). Contact the study team or your healthcare provider for specific answers.

What this study is about